Key result
Infective endocarditis maintains ~20% in-hospital mortality, underscoring the need for multidisciplinary team care.
Why the study?
The population at risk of infective endocarditis is growing with increasing device implantations, while diagnosis remains difficult and requires novel microbiological and imaging techniques alongside evolving multidisciplinary management.
This narrative review synthesizes current evidence on the shifting epidemiology (older patients, cardiac devices, TAVI, injection drug use), multimodality diagnostic workup, and multidisciplinary Endocarditis Team management of infective endocarditis.
Answers are grounded in this paper and cite their sources.
Persistent mortality demands Endocarditis Team care; leaves open optimal integration of multimodality imaging in device-related cases.
Infective endocarditis (IE) is a rare but potentially life-threatening disease, sometimes with longstanding sequels among surviving patients. The population at high risk of IE is represented by patients with underlying structural heart disease and/or intravascular prosthetic material. Taking into account the increasing number of intravascular and intracardiac procedures associated with device implantation, the number of patients at risk is growing too. If bacteremia develops, infected vegetation on the native/prosthetic valve or any intracardiac/intravascular device may occur as the final result of invading microorganisms/host immune system interaction. In the case of IE suspicion, all efforts must be focused on the diagnosis as IE can spread to almost any organ in the body. Unfortunately, the diagnosis of IE might be difficult and require a combination of clinical examination, microbiological assessment and echocardiographic evaluation. There is a need of novel microbiological and imaging techniques, especially in cases of blood culture-negative. In the last few years, the management of IE has changed. A multidisciplinary care team, including experts in infectious diseases, cardiology and cardiac surgery, namely, the Endocarditis Team, is highly recommended by the current guidelines.
No takes yet. Share an insight, caveat, or question.
Cimmino et al. (2023) conducted a review in Infective endocarditis (IE). Multidisciplinary Endocarditis Team management, multimodality diagnostic imaging, tailored antibiotic therapy, and early surgery was evaluated. Infective endocarditis continues to carry an in-hospital mortality of 14-22% and 3-month mortality of 18-25%, requiring multimodality imaging and multidisciplinary Endocarditis Team management.
Synapse has enriched 10 related papers. Consider them for comparative context: